Back

Head to head comparison of ECPELLA versus venoarterial-ECMO in Myocardial Infarction associated cardiogenic shock: a meta-analysis

29 August 2026 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: update on cardiogenic shock Cardiogenic Shock ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor George Chatzis

Philipps University of Marburg, Marburg (Germany)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on contemporary management of cardiogenic shock in heart failure
Professor M. Metra (Milan, IT)
Presentation thumbnail
Prognostic impact of frailty beyond age in cardiogenic shock
Doctor J. Ha (Seoul, KR)
Abstract
Presentation thumbnail
Sex-specific utilization patterns of advanced therapies in MI-related cardiogenic shock : a five year US National Analysis
Doctor V. Polana (Brooklyn, US)
Abstract
Presentation thumbnail
Effect of microaxial flow pump on survival in isolated left main infarction related cardiogenic shock. A DanGer Shock substudy analysis
Doctor J. Andersen (Odense, DK)
Abstract

Access the full session

Session thumbnail
Acute heart failure: update on cardiogenic shock

The Event

Event poster

ESC Congress 2026

29 August 2026 08:33 CET
You may be interested in
thumbnail
Congress Presentation
Impact of the combined use of VA-ECMO and impella (ECPELLA) on short-term mortality in cardiogenic shock patients receiving VA-ECMO: a propensity score-matched analysis
29 August 2025
thumbnail
Congress Presentation
The effect of low- and high-mean arterial pressure levels on short-term mortality in cardiac arrest and cardiogenic shock due to acute myocardial infarction: a meta-analysis
31 August 2025
thumbnail
Congress Presentation
Differences in mortality between patients with cardiogenic shock due to STEMI treated with PCI vs thrombolysis
9 March 2024
thumbnail
Congress Presentation
Complications of temporary mechanical circulatory support in cardiogenic shock: a systematic review and meta-analysis
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources